We are live on
!
Find out more
DCM
Driehaus Capital Management Portfolio holdings
AUM
$13.6B
1-Year Est. Return
173.98%
This Fund
S&P 500
This Quarter
Est. Return
+4.28%
1 Year Est. Return
+173.98%
3 Year Est. Return
+706.72%
5 Year Est. Return
+1,585.86%
10 Year Est. Return
+31,592.09%
AUM
$7.69B
AUM Growth
-$228M
(-2.9%)
Cap. Flow
-$66.9M
Cap. Flow
% of AUM
-0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.39%
Holding
467
New
87
Increased
134
Reduced
143
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Camtek
CAMT
|
+$69.7M |
| 2 |
Tidewater
TDW
|
+$49.7M |
| 3 |
Onto Innovation
ONTO
|
+$45.1M |
| 4 |
Noble Corp
NE
|
+$45M |
| 5 |
Synopsys
SNPS
|
+$43.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
+$94.7M |
| 2 |
Iridium Communications
IRDM
|
+$61.9M |
| 3 |
Inspire Medical Systems
INSP
|
+$49M |
| 4 |
Wingstop
WING
|
+$47.9M |
| 5 |
Installed Building Products
IBP
|
+$47.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.55% |
| 2 | Industrials | 20.08% |
| 3 | Healthcare | 18.28% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Consumer Staples | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXAS
251
DELISTED
Exact Sciences
EXAS
| $7.06M | 0.09% |
103,459
-48,690
| -32% | -$4.13M |
|
|
WCC
252
WESCO International
WCC
$17.6B
| $7M | 0.09% |
48,680
-40,358
| -45% | -$6.52M |
|
253
Liberty Media Series C
FWONK
$24.5B
| $6.97M | 0.09% |
+111,847
| New | +$7.68M |
|
254
Houlihan Lokey
HLI
$8.77B
| $6.94M | 0.09% |
+64,775
| New | +$6.68M |
|
|
BLD
255
DELISTED
TopBuild
BLD
| $6.92M | 0.09% |
27,503
-84,877
| -76% | -$23.4M |
|
256
Alnylam Pharmaceuticals
ALNY
$29.5B
| $6.91M | 0.09% |
39,029
-9
| -0% | -$1.72K |
|
|
APLS
257
DELISTED
Apellis Pharmaceuticals
APLS
| $6.9M | 0.09% |
181,324
-166,052
| -48% | -$7.29M |
|
258
Beazer Homes USA
BZH
$901M
| $6.83M | 0.09% |
+274,080
| New | +$7.91M |
|
259
Tactile Systems Technology
TCMD
$672M
| $6.78M | 0.09% |
482,835
+51,534
| +12% | +$1.01M |
|
260
Monolithic Power Systems
MPWR
$66B
| $6.78M | 0.09% |
14,665
+287
| +2% | +$147K |
|
261
D.R. Horton
DHI
$41B
| $6.73M | 0.09% |
62,655
-76,909
| -55% | -$9.21M |
|
|
ETNB
262
DELISTED
89bio
ETNB
| $6.67M | 0.09% |
432,174
-937
| -0.2% | -$15.7K |
|
|
GMS
263
DELISTED
GMS Inc
GMS
| $6.62M | 0.09% |
103,556
-42,495
| -29% | -$2.95M |
|
264
LeMaitre Vascular
LMAT
$2.37B
| $6.59M | 0.09% |
120,891
+17,982
| +17% | +$1.07M |
|
265
PDF Solutions
PDFS
$2.01B
| $6.53M | 0.08% |
201,522
-432
| -0.2% | -$16.5K |
|
266
Ingredion
INGR
$6.33B
| $6.52M | 0.08% |
66,231
-33,804
| -34% | -$3.51M |
|
267
Rhythm Pharmaceuticals
RYTM
$7.05B
| $6.29M | 0.08% |
274,524
+251,531
| +1,094% | +$5.63M |
|
|
SOVO
268
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $6.27M | 0.08% |
277,926
-1,577,301
| -85% | -$33.2M |
|
269
Revolution Medicines
RVMD
$38.8B
| $6.04M | 0.08% |
218,153
-490
| -0.2% | -$14.5K |
|
270
Yext
YEXT
$569M
| $6M | 0.08% |
947,393
-2,069
| -0.2% | -$17.7K |
|
271
Magnite
MGNI
$2.8B
| $6M | 0.08% |
795,157
-1,205,011
| -60% | -$13M |
|
|
DAWN
272
DELISTED
Day One Biopharmaceuticals
DAWN
| $5.99M | 0.08% |
488,318
+10,212
| +2% | +$133K |
|
273
Target Hospitality
TH
$1.57B
| $5.97M | 0.08% |
375,949
+45,984
| +14% | +$648K |
|
|
274
Wingstop
WING
$3.55B
| $5.63M | 0.07% |
31,332
-277,024
| -90% | -$47.9M |
|
|
SCRM
275
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
| $5.5M | 0.07% |
525,785
| – | – |
|
Similar funds
CC
PMAM
SA
PSCM
WHG
AA
WA
SAM
Driehaus Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Driehaus Capital Management held 467 positions worth $7.69B, down 2.9% from $7.92B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Driehaus Capital Management's Q3 2023 filing shows 87 new, 134 increased, 143 reduced and 77 closed positions. Its largest new stake was Camtek: 1,412,510 shares worth $87.9M. The largest sale was DICE Therapeutics, Inc. Common Stock, an estimated $94.7M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Healthcare.
- Driehaus Capital Management's largest Q3 2023 buy was Camtek: 1,412,510 shares worth $87.9M.
- Driehaus Capital Management added most to Structure Therapeutics in Q3 2023, an estimated $40.4M increase.
- Driehaus Capital Management's biggest Q3 2023 reduction was Inspire Medical Systems, cutting an estimated $49M.
- Driehaus Capital Management fully exited DICE Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $94.7M.
- Driehaus Capital Management's ten largest holdings make up 18% of its $7.69B portfolio in Q3 2023.
- Driehaus Capital Management opened 87 new positions and closed 77 in Q3 2023.
- Driehaus Capital Management's portfolio value fell 2.9% quarter-over-quarter to $7.69B.
Based on Driehaus Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.